% 565.9 78.2% 4.8 0.9% Cost of Sales 12.9 1.7% 157.5 4.3% 144.6 1121.1% Gross Profit 152.4 20.4% 156.16 12.6% 3.8 2.5% Gain from fair value adjustment on investment property 6.4 0.9% -3.5 -0.5% -9.9 -154.7

to The Company 64.83 48.29 34% * Non-cash items included depreciation as well as accounting adjustment Page 2 of 4 Revenue from Hospital Operations Revenue from hospital operations of the 2nd quarter

The Company 82.77 176.41 -53% * Non-cash items included depreciation as well as accounting adjustment Page 2 of 4 Revenue from hospital operations of the first quarter of 2020 (“1Q’20”) was THB 447.23

and its subsidiaries had total shareholder equity of 423.3 MB which decreased from December 31, 2019 in amount of 24.8 MB due to the adjustment of the cumulative effects from the retained earnings by

Persons (Private Placement) 4. Information Memorandum on the Issuance and the Allocation of the newly issued Shares to Accommodate the Right Adjustment of the Warrant to Purchase the newly issued Shares of

servicing projects as well as costs related to development of renewable energy projects overseas of THB 0.52 million. - Cost of sales For the 9-month period ended 30 September 2017 and 2018, costs of

Deferred Revenue Item Deferred Revenue Item = Deferred revenue from assets monetization to WHABT in 2015 which recognized in the first quarter of 2019 as a result of accounting standard adjustment (TFRS 15

(Private Placement) 4. Information Memorandum on the Issuance and the Allocation of the newly issued Shares to Accommodate the Right Adjustment of the Warrant to Purchase the newly issued Shares of the

Baht 1, in the amount of Baht 1,974,500 (Baht one million, nine hundred seventy four thousand, and five hundred) to be reserved for the right adjustment of warrant CCET-WB . The detailed calculation of

fiscal year 2020. The above auditors are authorized to review and give opinion on the financial statement of the Company and its subsidiaries as well as approved the audit fee of the Company for the fiscal